Arctoris contributes its capabilities and expertise to the fight against COVID-19
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases
Promega automated sample preparation solution added to CDC COVID-19 test protocol
The test is intended to expand availability of COVID-19 screening resources in central Ohio
New platform builds on Cytel’s East software to deliver adaptive clinical trial design and analysis
Interim data shows strong antibody and T-cell responses in all evaluated participants
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
The bridging assay aims to allow a full-length trimeric Spike protein from the COVID-19 virus to be used as both a capture and detection tool
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
Delivers major improvements for discoveries in immunology, oncology, autoimmunity, and infectious diseases
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
First subjects recently administered immunizations in two studies of 20-valent pneumococcal conjugate vaccine candidate in infants; a pentavalent meningococcal vaccine candidate in adolescents; and a respiratory syncytial virus vaccine candidate in pregnant women
Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019
The collaboration also includes the University of Coventry, UCB, and is supported by EIT Digital.
Roche will access SpeeDx existing tests and technology to expand diagnostic products for the management of antibiotic resistance in STIs
These four viral infections have similar patient presentations, making accurate detection and differentiation critical during next flu season